Asia-Pacific ECMO Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Modality (Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO), Application (Respiratory and Cardiology), and Age Group (Adults, Pediatrics, and Neonates)

The Asia-Pacific ECMO market is expected to grow from US$ 110.85 million in 2022 to US$ 139.19 million by 2028. It is estimated to record a CAGR of 3.9% from 2022 to 2028.

Increasing Survival Rates with ECMO to Offer Opportunities for Asia-Pacific ECMO Market During 2022–2028

The employment of ECMO for treating respiratory failure has been increasing in recent years, as treatments with ECMO show promising survival rates. Further, ECMO is recommended to treat patients suffering from acute respiratory distress syndrome (ADRS), primary graft dysfunction post lung transplant, and trauma to the lungs as it increases the survival rate of patients. Furthermore, ECMO increases the survival rate of patients affected by post-cardiac arrest regimen. A radical shift in adopting westernized lifestyles leads to various cardiac disorders. Thus, key players invest significantly in R&D, which results in improved treatment outcomes with ECMO with an increased survival rate. Therefore, the rising survival rate with ECMO use in various treatments is expected to provide lucrative opportunities for ECMO market in Asia-Pacific during the forecast period.

Asia-Pacific ECMO Market Overview

Asia-Pacific is the fastest-growing regional ECMO market. China, India, and Japan are major contributors to the Asia-Pacific ECMO market growth in the region. China dominated the market in 2022. According to an article by the National Center for Biotechnology Information (NCBI) titled "Cardiovascular Health and Diseases in China," Cardiovascular Disease (CVD) accounted for ~47% and 44% of all deaths in rural and urban areas, respectively, in 2019. Two out of every five deaths occur due to CVD, and it is predicted that over 330 million patients suffer from CVD in China. The patients suffering from stroke, heart failure, coronary heart disease, pulmonary heart disease, rheumatic heart disease, atrial fibrillation, lower extremity artery disease, congenital heart disease, and hypertension were found to be 13 million, 11 million, 9 million, 5 million, 4.87 million, 2.50 million, 2 million, 45.30 million, and 245.00 million, respectively. Moreover, according to Statista data, the population aged above 60 years is estimated to grow from 17.4% in 2020 to 30% by 2040. Thus, China is facing the pressures of an aging population and the constant rise in the prevalence of metabolic risk factors. As a result, the CVD burden will continue to increase, setting new requirements for CVD prevention, treatment, and the allocation of medical resources in China. Furthermore, the penetration of international market players in the country is boosting the growth of the ECMO market. In July 2021, Xenios AG, a Fresenius Medical Care company, received approval from the National Medical Products Administration (NMPA) in China for the Xenios console and patient kits for ECMO therapy. Hence, the rising prevalence of CVD, the increasing geriatric population, and advancements by key players are expected to propel the ECMO market in China during the forecast period.

Asia-Pacific ECMO Market Revenue and Forecast to 2028 (US$ Million)

APAC ECMO Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

Asia-Pacific ECMO Market Segmentation

The Asia-Pacific ECMO market is segmented based on modality, application, age group, and country.

Based on modality, the Asia-Pacific ECMO market is segmented into venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO. The venoarterial ECMO segment held the largest market share in 2022.

Based on application, the Asia-Pacific ECMO market is bifurcated into respiratory and cardiology. The respiratory segment held a larger market share in 2022.

Based on age group, the Asia-Pacific ECMO market is segmented into adults, pediatrics, and neonates. The adults segment held the largest market share in 2022.

Based on country, the Asia-Pacific ECMO market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. Our regional analysis states that China dominated the market in 2022.

ABIOMED Inc, Braile Biomedica, Eurosets S.R.L., Fresenius Medical Care AG & Co KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corporation, Nipro Medical Corporation, and Terumo Group are the leading companies operating in the Asia-Pacific ECMO market.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia-Pacific ECMO Market – By Modality

1.3.2 Asia-Pacific ECMO Market – By Application

1.3.3 Asia-Pacific ECMO Market – By Age Group

1.3.4 Asia-Pacific ECMO Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia-Pacific ECMO Market – Market Landscape

4.1 Overview

4.2 Asia-Pacific PEST Analysis

4.3 Experts Opinion

5. Asia-Pacific ECMO Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Cardiovascular Diseases and Respiratory Failures

5.1.2 Growing Adoption of ECMO in Lung Transplantation Procedures

5.2 Market Restraints

5.2.1 Complications Associated with ECMO

5.3 Market Opportunities

5.3.1 Increasing Survival Rates with ECMO

5.4 Future Trends

5.4.1 Surging Product Developments and Approvals

5.5 Impact Analysis

6. ECMO Market – Asia-Pacific Analysis

6.1 Asia-Pacific ECMO Market Revenue Forecast & Analysis

7. Asia-Pacific ECMO Market Analysis – By Modality

7.1 Overview

7.2 Asia-Pacific ECMO Market Share by Modality 2021 & 2028 (%)

7.3 Venoarterial ECMO

7.3.1 Overview

7.3.2 Venoarterial ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)

7.4 Venovenous ECMO

7.4.1 Overview

7.4.2 Venovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)

7.5 Arteriovenous ECMO

7.5.1 Overview

7.5.2 Arteriovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)

8. Asia-Pacific ECMO Market Analysis – By Application

8.1 Overview

8.2 Asia-Pacific ECMO Market, By Application 2021 & 2028 (%)

8.4 Respiratory

8.4.1 Overview

8.4.2 Respiratory Market Revenue and Forecast to 2028 (US$ Mn)

8.5 Cardiology

8.5.1 Overview

8.5.2 Cardiology Market Revenue and Forecast to 2028 (US$ Mn)

9. Asia-Pacific ECMO Market Analysis – By Age Group

9.1 Overview

9.2 Asia-Pacific ECMO Market, By Age Group 2021 & 2028 (%)

9.3 Adults

9.3.1 Overview

9.3.2 Adults Market Revenue and Forecast to 2028 (US$ Mn)

9.4 Pediatrics

9.4.1 Overview

9.4.2 Pediatrics Market Revenue and Forecast to 2028 (US$ Mn)

9.5 Neonates

9.5.1 Overview

9.5.2 Neonates Market Revenue and Forecast to 2028 (US$ Mn)

10. Asia-Pacific ECMO Market – Country Analysis

10.1 Overview

10.1.1 Asia-Pacific: ECMO Market, by Country, 2021 & 2028 (%)

10.1.1.1 China: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 China: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 China: ECMO Market, by Modality, 2020–2028 (US$ Million)

10.1.1.1.4 China: ECMO Market, by Application, 2020–2028 (US$ Million)

10.1.1.1.5 China: ECMO Market, by Age Group, 2020–2028 (US$ Million)

10.1.1.2 Japan: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Japan: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 Japan: ECMO Market, by Modality, 2020–2028 (US$ Million)

10.1.1.2.4 Japan: ECMO Market, by Application, 2020–2028 (US$ Million)

10.1.1.2.5 Japan: ECMO Market, by Age Group, 2020–2028 (US$ Million)

10.1.1.3 India: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 India: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 India: ECMO Market, by Modality, 2020–2028 (US$ Million)

10.1.1.3.4 India: ECMO Market, by Application, 2020–2028 (US$ Million)

10.1.1.3.5 India: ECMO Market, by Age Group, 2020–2028 (US$ Million)

10.1.1.4 South Korea: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 South Korea: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3 South Korea: ECMO Market, by Modality, 2020–2028 (US$ Million)

10.1.1.4.4 South Korea: ECMO Market, by Application, 2020–2028 (US$ Million)

10.1.1.4.5 South Korea: ECMO Market, by Age Group, 2020–2028 (US$ Million)

10.1.1.5 Australia: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 Australia: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3 Australia: ECMO Market, by Modality, 2020–2028 (US$ Million)

10.1.1.5.4 Australia: ECMO Market, by Application, 2020–2028 (US$ Million)

10.1.1.5.5 Australia: ECMO Market, by Age Group, 2020–2028 (US$ Million)

10.1.1.6 Rest of Asia-Pacific: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Asia-Pacific: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3 Rest of Asia-Pacific: ECMO Market, by Modality, 2020–2028 (US$ Million)

10.1.1.6.4 Rest of Asia-Pacific: ECMO Market, by Application, 2020–2028 (US$ Million)

10.1.1.6.5 Rest of Asia-Pacific: ECMO Market, by Age Group, 2020–2028 (US$ Million)

11. Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Terumo Group

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Medtronic Plc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 MicroPort Scientific Corporation

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 LivaNova Plc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Nipro Medical Corporation

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Eurosets S.R.L.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Getinge AB

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Braile Biomedica

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Fresenius Medical Care AG & Co KGaA

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 ABIOMED Inc

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Table 2. China ECMO Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 3. China ECMO Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 4. China ECMO Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 5. Japan ECMO Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 6. Japan ECMO Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 7. Japan ECMO Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 8. India ECMO Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 9. India ECMO Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 10. India ECMO Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 11. South Korea ECMO Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 12. South Korea ECMO Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 13. South Korea ECMO Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 14. Australia ECMO Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 15. Australia ECMO Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 16. Australia ECMO Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 17. Rest of Asia-Pacific ECMO Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 18. Rest of Asia-Pacific ECMO Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 19. Rest of Asia-Pacific ECMO Market, by Age Group– Revenue and Forecast to 2028 (US$ Million)

Table 20. Recent Inorganic Growth Strategies

Table 21. Recent Organic Growth Strategies

Table 22. Glossary of Terms

LIST OF FIGURES

Figure 1. Asia-Pacific ECMO Market Segmentation

Figure 2. Asia-Pacific ECMO Market, By Country

Figure 3. Asia-Pacific ECMO Market Overview

Figure 4. Asia-Pacific ECMO Market, By Modality

Figure 5. Asia-Pacific ECMO Market, By Country

Figure 7. Asia-Pacific: PEST Analysis

Figure 8. Experts Opinion

Figure 9. Impact Analysis: Asia-Pacific ECMO Market

Figure 10. Asia-Pacific ECMO Market – Revenue Forecast and Analysis

Figure 11. Asia-Pacific ECMO Market Share by Modality 2021 & 2028 (%)

Figure 12. Venoarterial ECMO: Asia-Pacific ECMO Market Revenue and Forecast To 2028 (US$ Million)

Figure 13. Venovenous ECMO: Asia-Pacific ECMO Market Revenue and Forecast To 2028 (US$ Million)

Figure 14. Arteriovenous ECMO: Asia-Pacific ECMO Market Revenue and Forecast To 2028 (US$ Million)

Figure 15. Asia-Pacific ECMO Market, by Application 2021 & 2028 (%)

Figure 16. Respiratory : Asia-Pacific ECMO Market Revenue and Forecasts To 2028 (US$ MN)

Figure 17. Cardiology : Asia-Pacific ECMO Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. Asia-Pacific ECMO Market, by Age Group 2021 & 2028 (%)

Figure 19. Adults : Asia-Pacific ECMO Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. Pediatrics : Asia-Pacific ECMO Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. Neonates : Asia-Pacific ECMO Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. Asia-Pacific: ECMO Market, by Key Country – Revenue (2021) (US$ Million)

Figure 23. Asia-Pacific: ECMO Market, by Country, 2021 & 2028 (%)

Figure 24. China: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Japan: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. India: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. South Korea: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Australia: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Rest of Asia-Pacific: ECMO Market – Revenue and Forecast to 2028 (US$ Million)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia-Pacific ECMO market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia-Pacific ECMO market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia-Pacific market trends and outlook coupled with the factors driving the ECMO market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000